New hope for Tough-to-Treat lymphoma: trial tests Next-Gen cell therapy
Disease control
Recruiting now
This trial is testing a new, experimental CAR-T cell therapy called WZTL-002 for people with aggressive large B-cell lymphoma that has returned or not responded to standard chemotherapy. The main goals are to see how well the therapy works to eliminate the cancer and to understan…
Phase: PHASE2 • Sponsor: Malaghan Institute of Medical Research • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC